- Tytuł:
- Immunogenicity and safety of a recombinant COVID-19 vaccine (ZF2001) as heterologous booster after priming with inactivated vaccine in healthy children and adolescents aged 3-17 years: an open-labeled, single-arm clinical trial.
- Autorzy:
- Źródło:
- BMC Infectious Diseases. 4/19/2024, Vol. 24 Issue 1, p1-9. 9p.
Czasopismo naukowe